Concepedia

Li Li

LL

Statistics

Publications

47

Citations

2.5K

H-Index

23

Active since

2003

Affiliations

Gilead Sciences (United States)(Current)

Chinese Center For Disease Control and Prevention

Taiwan Centers for Disease Control

Capital Medical University

Centers for Disease Control and Prevention

Li Li is an author at Gilead Sciences (United States) specializing in viral hepatitis, infectious diseases, and viral hepatitis treatment.

ORCID

Publications per year

2003–2025

47

Publications

47

Prevention of Chronic Hepatitis B after 3 Decades of Escalating Vaccination Policy, China

Fuqiang Cui, Lipin Shen, Li Li et al. · Emerging infectious diseases · 2017 · 380 citations · Full text

, , +17

Evaluation of the Impact of Hepatitis B Vaccination among Children Born during 1992–2005 in China

Xiaofeng Liang, Shengli Bi, Weizhong Yang et al. · The Journal of Infectious Diseases · 2009 · 283 citations

, , +17

Sustained efficacy and seroconversion with the Toll-like receptor 7 agonist GS-9620 in the Woodchuck model of chronic hepatitis B

Stephan Menne, Daniel B. Tumas, Katherine H. Liu et al. · Journal of Hepatology · 2015 · 203 citations · Full text

, , +17

Reprint of: Epidemiological serosurvey of Hepatitis B in China—Declining HBV prevalence due to Hepatitis B vaccination

Xiaofeng Liang, Shengli Bi, Weizhong Yang et al. · Vaccine · 2013 · 154 citations

, , +11

The Smc5/6 Complex Restricts HBV when Localized to ND10 without Inducing an Innate Immune Response and Is Counteracted by the HBV X Protein Shortly after Infection

Congrong Niu, Christine M. Livingston, Li Li et al. · PLoS ONE · 2017 · 153 citations · Full text

, , +17

1–5 of 47